June 16, 2023 Comments Off on New patent for Amneal drug LYVISPAH Posted in: Patent Added Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent for Amneal drug LYVISPAH appeared first on DrugPaten…
June 16, 2023 Comments Off on New patent for Array Biopharma drug MEKTOVI Posted in: Patent Added Annual Drug Patent Expirations for MEKTOVI Mektovi is a drug marketed by Array Biopharma Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Array Biopharma drug MEKTOVI appeared first on DrugPatent…
